Skip to main content

ADVERTISEMENT

Non-Small-Cell Lung Cancer

News
12/11/2020
Edward B. Garon MD, MS, engaged in a stimulating debate regarding the relevancy of angioinhibition in the management of NSCLC, particularly for EGFR-positive patients, at the virtual 2020 Personalized Therapies in Thoracic Oncology meeting.
Edward B. Garon MD, MS, engaged in a stimulating debate regarding the relevancy of angioinhibition in the management of NSCLC, particularly for EGFR-positive patients, at the virtual 2020 Personalized Therapies in Thoracic Oncology meeting.
Edward B. Garon MD, MS, engaged...
12/11/2020
Oncology
Aaron Lisberg, MD, On Treatment Approaches for Oncogene-Driven NSCLC
Conference Insider
11/20/2020
Dr Lisberg discusses when to use checkpoint inhibitor therapy for targetable mutations in NSCLC, a recap of his presentation at the 2020 Personalized Therapies in Thoracic Oncology meeting.
Dr Lisberg discusses when to use checkpoint inhibitor therapy for targetable mutations in NSCLC, a recap of his presentation at the 2020 Personalized Therapies in Thoracic Oncology meeting.
Dr Lisberg discusses when to use...
11/20/2020
Oncology
Clinical Use of Liquid Biopsies in Lung Cancer
Debates and Roundtables
10/06/2020
Joshua Bauml, MD, Lyudamila Bazhenova, MD, Jarushka Naidoo, M.B.B.Ch, discuss evolution and utilization of liquid biopsies in NSCLC in part 1 of this virtual roundtable discussion.
Joshua Bauml, MD, Lyudamila Bazhenova, MD, Jarushka Naidoo, M.B.B.Ch, discuss evolution and utilization of liquid biopsies in NSCLC in part 1 of this virtual roundtable discussion.
Joshua Bauml, MD, Lyudamila...
10/06/2020
Oncology
Conference Insider
09/19/2020
Among patients with NSCLC receiving gemcitabine-carboplatin chemo, neutropenia may predict OS, according to long-term follow-up data presented at the ESMO 2020 Virtual Congress.
Among patients with NSCLC receiving gemcitabine-carboplatin chemo, neutropenia may predict OS, according to long-term follow-up data presented at the ESMO 2020 Virtual Congress.
Among patients with NSCLC...
09/19/2020
Oncology
Remarkable Breakthroughs in the Treatment of Advanced NSCLC
Videos
03/22/2020
Martin J. Edelman, MD, discusses how the treatment landscape for advanced NSCLC has evolved in recent years.
Martin J. Edelman, MD, discusses how the treatment landscape for advanced NSCLC has evolved in recent years.
Martin J. Edelman, MD, discusses...
03/22/2020
Oncology
The Future of Lung Cancer Screening
Videos
03/03/2020
James L. Mulshine, MD, talks about what the future holds vis-a-vis advancements in lung cancer screening.
James L. Mulshine, MD, talks about what the future holds vis-a-vis advancements in lung cancer screening.
James L. Mulshine, MD, talks...
03/03/2020
Oncology
The Role of Surgery in Locally Advanced NSCLC
Videos
02/26/2020
Jessica Donington, MD, discusses the role of surgery in managing patients with locally advanced NSCLC.
Jessica Donington, MD, discusses the role of surgery in managing patients with locally advanced NSCLC.
Jessica Donington, MD, discusses...
02/26/2020
Oncology
News
01/08/2020
Findings from a pooled analysis of 4 clinical trials showed a link between high BMI and improved OS in patients with advanced NSCLC treated with atezolizumab.
Findings from a pooled analysis of 4 clinical trials showed a link between high BMI and improved OS in patients with advanced NSCLC treated with atezolizumab.
Findings from a pooled analysis...
01/08/2020
Oncology
Videos
12/02/2019
Jessica Donington, MD, talks about old approaches and new directions in the treatment of patients with mesothelioma.
Jessica Donington, MD, talks about old approaches and new directions in the treatment of patients with mesothelioma.
Jessica Donington, MD, talks...
12/02/2019
Oncology
Videos
11/26/2019
Christine Ciunci, MD, MSCE, Penn Presbyterian Medical Center, spoke about the use of neoadjuvant versus adjuvant treatment in patients with early-stage NSCLC.
Christine Ciunci, MD, MSCE, Penn Presbyterian Medical Center, spoke about the use of neoadjuvant versus adjuvant treatment in patients with early-stage NSCLC.
Christine Ciunci, MD, MSCE, Penn...
11/26/2019
Oncology